Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 Next >
Leading Investigators Highlight Advances in Photodynamic Therapy at the American Academy of Dermatology Annual Meeting
February 06, 2008
First-Line Treatment for Patients at Risk for Skin Cancer Evaluated for Potential Effectiveness for Wide Array of Dermatologic Needs Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports Third Quarter 2007 Financial Results and Corporate Highlights
November 09, 2007
Revenues Total $5.8 Million; Bottom Line Improves 50%; Initial Latin American Orders Shipped; Nicomide(R) Lawsuit Settled; Company Enhances Cash Position Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host Third Quarter Financial Results and Corporate Highlights Conference Call
November 01, 2007
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
October 30, 2007
from Marketwired News Releases
DUSA Pharmaceuticals Announces $11 Million in Private Placement of Common Stock and Warrants to Institutional Investors
October 30, 2007
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the CIBC World Markets 18th Annual Healthcare Conference
October 29, 2007
from Marketwired News Releases
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
October 29, 2007
River's Edge product no longer manufactured or distributed Read More
from Marketwired News Releases
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
October 08, 2007
More than 55 Presentations and Posters Featuring PDT Presented to the International Dermatology Community Read More
from Marketwired News Releases
DUSA's Levulan(R) Kerastick(R) Receives Marketing Approval in Korea
October 03, 2007
Levulan(R) Approval in Korea Expands DUSA's Global Market Reach Read More
from Marketwired News Releases
DUSA Expands Global Sales With Launch of Levulan(R) Kerastick(R) in Latin America
October 01, 2007
First Shipment Released to Argentina and Mexico Read More
from Marketwired News Releases
DUSA Pharmaceuticals to Present at Roth Capital Partners 2007 New York Conference
August 28, 2007
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Noble Financial Two Double-0-Seven Conference
August 15, 2007
from Marketwired News Releases
DUSA Pharmaceuticals Reports Second Quarter 2007 Corporate Highlights and Financial Results
August 07, 2007
Revenues total $6.9 million; Non-GAAP Bottom Line improves 44%; Initial Latin American Orders Received Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host Second Quarter Financial Results and Corporate Highlights Conference Call
August 02, 2007
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Jefferies Healthcare Conference on June 28
June 25, 2007
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
June 14, 2007
from Marketwired News Releases
DUSA Pharmaceuticals to Present at the Friedman, Billings, Ramsey & Co., Inc. 2007 Growth Conference
May 25, 2007
from Marketwired News Releases
Emerging Stock to Watch: LLSR! May 18, 2007
May 18, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Read More
from Marketwired News Releases
(OTC: USTA) 1st Quarter Earnings Soar
May 17, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
May 17, 2007
Researchers' Study Shows Promising Treatment for People Suffering from Barrett's Esophagus, a Leading Cause of Esophageal Cancer Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports First Quarter 2007 Corporate Highlights and Financial Results
May 04, 2007
Year over year revenues up 41% as Kerastick(R) unit sales increase 27% in the U.S.; Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call
May 01, 2007
from Marketwired News Releases
A New Angle to Treat Hard-To-Reach Acne
March 26, 2007
DUSA Pharmaceuticals Launches ClindaReach(TM) Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 Financial Results
March 16, 2007
Record Revenue of $8.2 million, Kerastick unit sales up 44% Highlight Fourth Quarter Results; Company Makes Further Progress on Product Development and International Distribution Initiatives; Company... Read More
from Marketwired News Releases
DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2006 Financial Results and Corporate Highlights Conference Call
March 13, 2007
from Marketwired News Releases
DUSA Pharmaceuticals Reports Court Ruling Lifting Injunction Against River's Edge Sales of Generic Nicomide(R)
March 07, 2007
DUSA will continue to pursue the case against River's Edge Read More
from Marketwired News Releases
International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
January 23, 2007
Unique System Treats Condition That May Lead to Squamous Cell Carcinoma Read More
from PR Newswire
DUSA Pharmaceuticals, Inc.: International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
January 23, 2007
from Marketwired
DUSA Pharmaceuticals, Inc.: International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
January 23, 2007
Unique System Treats Condition That May Lead to Squamous Cell Carcinoma Read More
from Marketwired News Releases
DUSA Pharmaceuticals Announces Exclusive Agreement with Daewoong to Market DUSA's Levulan'R' Kerastick'R' for Photodynamic Therapy in Asian Territories
January 08, 2007
Daewoong 'DNCompany' is the Largest Korean Pharmaceutical Company Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here